Prescription Review

## Prescription Review: Ofloxacin 0.3% Eye Drops, Refresh Tears, and Sodium Chloride 0.9% Eye Drops for Blepharitis and Dry Eye ### Prescription Summary | Parameter | Details | |-----------|---------| | **Institution** | Bệnh viện Quân y 175 (Vietnam) | | **Patient** | Male, age not specified | | **Diagnosis** | Viêm bờ mi (Blepharitis), Khô mắt (Dry eye) | | **Medication 1** | Ofloxacin 0.3% eye drops, 1 bottle, 4 times/day, 20 days | | **Medication 2** | Refresh Tears (Sodium Carboxymethylcellulose 0.5%), 1 bottle, 4 times/day, 15 days | | **Medication 3** | Sodium Chloride 0.9% eye drops, 1 bottle, frequency not specified, 14 days | --- ### Medication Rationality Review #### 1. Ofloxacin 0.3% Eye Drops **Indication Consistency**: The diagnosis is blepharitis. According to the Blepharitis Preferred Practice Pattern, topical antibiotic drops or ointments can be effective in the treatment of blepharitis[4]. The WHO Essential Medicines List includes ofloxacin 0.3% eye drops as a therapeutic alternative for bacterial conjunctivitis and bacterial keratitis[1]. The BSR guid: [已脱敏] on Sjögren disease notes that those with dry-eye disease associated with blepharitis could be offered short-term treatment with oral or topical antibiotics with anti-inflammatory action (Recommendation 2, B)[2]. **Dosage Assessment**: The prescribed frequency of 4 times/day is within the standard range for ophthalmic infections. For bacterial conjunctivitis, the ofloxacin label recommends 1-2 drops every 2-4 hours on days 1-2, then 4 times daily on days 3-7[3]. For blepharitis, the WHO AWaRe handbook provides a protocol of 1 drop every hour for 48 hours then every 4 hours until healed for corneal infections[6], though this is more intensive than typically needed for blepharitis. **Duration**: 20 days is a reasonable duration for blepharitis, which is typically a chronic condition requiring sustained treatment[4]. The WHO AWaRe handbook notes that treatment duration is often personalized based on clinical improvement[6]. **Assessment**: Appropriate. Ofloxacin is a fluoroquinolone with good ocular penetration and broad-spectrum coverage suitable for blepharitis. #### 2. Refresh Tears (Sodium Carboxymethylcellulose 0.5%) **Indication Consistency**: Dry eye is the second listed diagnosis. Artificial tears are the first-line treatment for aqueous deficiency dry eye[5]. The Cochrane review on OTC artificial tears found that artificial tears as a whole consistently improved ocular symptoms over the course of included trials, and are relatively safe[7]. **Dosage Assessment**: 4 times/day is within the standard recommendation. The CM DT 2023 states that artificial tears are generally safe and in most cases used 3-4 times a day[5]. Preservative-free preparations are recommended for any frequency of use greater than 4 times a day[5]. **Duration**: 15 days is appropriate for an initial treatment course. **Assessment**: Appropriate. Sodium carboxymethylcellulose is a mucomimetic that provides prolonged duration of action[5]. #### 3. Sodium Chloride 0.9% Eye Drops **Indication Consistency**: The CM DT 2023 states that the simplest preparations for aqueous deficiency are physiologic (0.9%) or hypo-osmotic (0.45%) solutions of sodium chloride, which can be used as frequently as every half-hour, but in most cases are needed only 3-4 times a day[5]. **Dosage Assessment**: The frequency is not specified on the prescription. This is a minor documentation issue. **Duration**: 14 days is reasonable. **Assessment**: Appropriate as a simple tear substitute, though its efficacy is likely inferior to mucomimetic-containing preparations like Refresh Tears. --- ### Interaction and Safety Check | Interaction Pair | Risk | Assessment | |-----------------|------|------------| | Ofloxacin + Refresh Tears | Low | No known significant interaction. Can be used sequentially with 5-minute interval between drops | | Ofloxacin + NaCl 0.9% | Low | No interaction. NaCl 0.9% is physiologically compatible | | Refresh Tears + NaCl 0.9% | Low | Both are tear substitutes; concurrent use is redundant but not harmful | **Safety Consid: [已脱敏]**: - Ofloxacin is contraindicated in patients with hypersensitivity to fluoroquinolones[3] - Preservative-free artificial tears are preferred if using more than 4 times/day[5] - No systemic drug interactions are expected with topical ophthalmic preparations --- ### Guid: [已脱敏]e Consistency **The following illustrates the clinical treatment protocols for bacterial conjunctivitis:** ![【WHO AWaRe Antibiotic Handbook / Clinical Guid: [已脱敏]s】Bacterial and Gonococcal Conjunctivitis Treatment Protocols](https://img.medsci.cn/knowledge_base/af7111c00180a6c5/_p_122_f_32.jpeg) *Figure: Clinical treatment protocols for bacterial and gonococcal conjunctivitis specifying antibiotic dosages and durations* **The following illustrates the treatment and prevention protocols for bacterial conjunctivitis in infants:** ![【WHO AWaRe Antibiotic Handbook / Clinical Guid: [已脱敏]s】Treatment and Prevention of Bacterial Conjunctivitis and Ophthalmia Neonatorum](https://img.medsci.cn/knowledge_base/af7111c00180a6c5/_p_124_f_4.jpeg) *Figure: Clinical guid: [已脱敏] for the treatment and prevention of bacterial conjunctivitis and ophthalmia neonatorum in infants* --- ### Critical Gaps - The frequency for sodium chloride 0.9% eye drops is not specified on the prescription - No information is available on whether the patient has contact lens wear, which would influence the choice of fluoroquinolone (ofloxacin is preferred for contact lens wearers due to Pseudomonas coverage)[6] - The BSR guid: [已脱敏] also recommends consid: [已脱敏] lipid: [已脱敏]ining eye drops or liposomal eye sprays as adjunctive treatment for dry eye associated with meibomian gland dysfunction (Recommendation 2, C)[2], which is not included in this prescription ### Conclusion This prescription is clinically appropriate for the dual diagnosis of blepharitis and dry eye. The combination of a topical antibiotic (ofloxacin) for the infectious/inflammatory component of blepharitis and artificial tears (Refresh Tears and NaCl 0.9%) for the dry eye component follows established clinical practice guid: [已脱敏]. The only documentation issue is the unspecified frequency for the sodium chloride eye drops. --- *This review is AI-generated based on retrieved literature and is intended for clinical reference only. Please verify all information against official drug labeling and exercise individual clinical judgment for each patient.*